All three major indices are trading down today with the

Dow Jones Industrial Average

(

^DJI

) trading down 34 points (-0.2%) at 16,609 as of Monday, Aug. 31, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,471 issues advancing vs. 1,509 declining with 154 unchanged.

The Health Care sector currently sits up 0.3% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the sector include

Regeneron Pharmaceuticals

(

REGN

), down 2.7%,

Alexion Pharmaceuticals

(

ALXN

), down 2.4%,

Merck

(

MRK

), down 2.2%,

Vertex Pharmaceuticals

(

VRTX

), down 2.1% and

Valeant Pharmaceuticals International

(

VRX

), down 1.9%.

TheStreet would like to highlight 3 stocks pushing the sector higher today:

3.

Medicines Company

(

MDCO

) is one of the companies pushing the Health Care sector higher today. As of noon trading, Medicines Company is up $6.00 (17.9%) to $39.64 on heavy volume. Thus far, 12.3 million shares of Medicines Company exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $37.33-$40.47 after having opened the day at $39.89 as compared to the previous trading day's close of $33.64.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

The Medicines Company provides medicines for patients in acute and intensive care hospitals worldwide. Medicines Company has a market cap of $2.1 billion and is part of the drugs industry. Shares are up 21.6% year-to-date as of the close of trading on Friday. Currently there are 3 analysts who rate Medicines Company a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates

Medicines Company

as a

hold

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full

Medicines Company Ratings Report

TheStreet Recommends

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Anthem

(

ANTM

) is up $2.14 (1.5%) to $142.70 on average volume. Thus far, 1.3 million shares of Anthem exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $139.95-$143.69 after having opened the day at $140.07 as compared to the previous trading day's close of $140.56.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. Anthem has a market cap of $37.2 billion and is part of the health services industry. Shares are up 11.8% year-to-date as of the close of trading on Friday. Currently there are 9 analysts who rate Anthem a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Anthem

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Anthem Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

Cigna

(

CI

) is up $3.66 (2.6%) to $141.53 on light volume. Thus far, 940,754 shares of Cigna exchanged hands as compared to its average daily volume of 3.2 million shares. The stock has ranged in price between $137.21-$142.10 after having opened the day at $137.21 as compared to the previous trading day's close of $137.87.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $35.6 billion and is part of the health services industry. Shares are up 34.0% year-to-date as of the close of trading on Friday. Currently there are 6 analysts who rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Cigna

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and growth in earnings per share. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Cigna Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).